Homologous or heterogenous vaccination boosters enhance neutralizing activities against SARS-CoV-2 Omicron BA.1 variant.
Zhou Z, Du P, Li N, Xiong X, Tang S, Dai Q, Wang T, Yu M, Man M, Lam K, Baptista-Hon DT, Tai WH, Monteiro O, Ng WS, Lee UM, Liu Z, Zhang K, Li G.
Zhou Z, et al. Among authors: tang s.
MedComm (2020). 2022 May 11;3(2):e143. doi: 10.1002/mco2.143. eCollection 2022 Jun.
MedComm (2020). 2022.
PMID: 35592756
Free PMC article.